ClinicalTrials.gg
Active, not recruitingNCT07936253SMART-M3Updated Nov 13, 2026

"Retrospective Study of the Risk of Pathology in the Mandibular Second Molar Associated With an Impacted Third Molar: Development and Validation of a Semi-Automated Artificial Intelligence-Based Digitisation Platform".

An observational study in Impacted Third Molar, Dental Caries and Alveolar Bone Resorption, sponsored by Universidad Católica San Antonio de Murcia. Active, not recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Universidad Católica San Antonio de Murcia · Observational

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,188
Ages
18 Years and older
Sex
All
01

Study summary

Impacted mandibular third molars (wisdom teeth that cannot fully erupt) may damage the adjacent second molar, causing decay on its back surface, loss of the supporting bone or resorption of its root. These problems are often silent and are detected late. This retrospective observational study aims to identify which radiographic features of the impacted third molar are associated with a higher risk of pathology in the second molar.

The study uses panoramic radiographs (OPG) and cone-beam computed tomography (CBCT) scans that were previously obtained for clinical reasons at the UCAM Dental University Clinic (Murcia, Spain) between 2018 and 2026. No new images or procedures are performed on patients. The position, angulation, depth and contact of the third molar with the second molar are measured, and their relationship with second molar pathology is analysed. The study also compares the information provided by OPG and CBCT and develops and validates a semi-automated, artificial intelligence-based platform to help clinicians make these radiographic measurements faster and more consistently.

Read the detailed description

Design. Single-centre, observational, cross-sectional, retrospective study approved by the Ethics Committee of the Universidad Católica San Antonio de Murcia (code CE102517). It follows the Declaration of Helsinki. Informed consent was waived because only pre-existing images obtained for clinical purposes are used. Data are pseudonymised in accordance with Regulation (EU) 2016/679 (GDPR) and Spanish Organic Law 3/2018.

Setting and sample. Consecutive sampling of all eligible images acquired at the UCAM Dental University Clinic between February 2018 and June 2026 with an ORTHOPHOS SL 3D unit (Dentsply Sirona). The unit of analysis is the mandibular third molar, so each patient may contribute one to four records (one or two third molars, on OPG, CBCT or both). The expected sample is approximately 2,110 third molars from 1,188 patients on OPG and approximately 690 third molars from 384 patients on CBCT, with a paired OPG-CBCT subsample of 667 teeth.

Variables. Third molar variables are:

  • Winter classification
  • Pell \& Gregory depth and ramus relationship
  • Retromolar space
  • Angle between the long axes of the second and third molars
  • Distance from the distal surface of the second molar to the ramus
  • Mesiodistal diameter of the third molar
  • Presence, type and level of contact between the third and second molars Covariates are age, sex and smoking status. Outcome. The primary outcome is a composite of distal pathology of the mandibular second molar, defined as the presence of at least one of the following: distal caries, distal bone loss or external root resorption. Teeth without any of the three are classified as controls. Each component is also recorded separately, with its extent or severity.

Statistical analysis. The analysis comprises:

  • Descriptive statistics, overall and by imaging modality.
  • Bivariate analysis using chi-square or Fisher's exact tests and Mann-Whitney U or Student's t tests, with odds ratios, 95% confidence intervals and correction for multiple comparisons.
  • Multivariable mixed-effects logistic regression with the patient as a random effect, to account for the clustering of teeth within patients.
  • Assessment of the model's discrimination with ROC curves and AUC.
  • Agreement between OPG and CBCT in the paired subsample, using intraclass correlation coefficients, simple and weighted kappa and Bland-Altman analysis, with 95% confidence intervals obtained by patient-clustered bootstrap.
  • Intra-observer reliability on 123 teeth per modality. AI-based platform. A semi-automated digitisation platform based on artificial intelligence (automatic landmark detection) is developed to perform the radiographic measurements. It is validated against expert manual assessment in an independent subsample of 191 third molars (103 OPG and 88 CBCT).
02

Conditions studied

  • Impacted Third Molar
  • Dental Caries
  • Alveolar Bone Resorption
  • Root Resorption

Keywords

  • panoramic radiography
  • cone-beam computed tomography
  • second molar
03

In context

Dental Caries

1,175 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

This study's enrollment of 1,188 is above the median of 169 across 191 observational studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Universidad Católica San Antonio de Murcia is the lead sponsor of 139 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients (18 years or older) who attended the UCAM Dental University Clinic (Murcia, Spain) between February 2018 and June 2026 and had at least one mandibular third molar visible on a panoramic radiograph (OPG) and/or cone-beam computed tomography (CBCT) scan obtained previously for clinical purposes. Patients were identified consecutively through the clinic's records management software (GESDEN).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Age and sex recorded.
  • At least one mandibular third molar present.
  • OPG and/or CBCT available.

Exclusion criteria

Exclusion Criteria:

  • Absence of the adjacent second mandibular molar.
  • Insufficient diagnositc image quality.
  • Previous surgery altering the anatomy.
  • Cysts or tumours in the third molar region.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,188 participants (actual)
Patient registry
No

Groups and cohorts

  • OPG cohort

    Patients with an impacted mandibular third molar assessed on panoramic radiography.

    Diagnostic Test: Radiographic assessment (OPG / CBCT)

  • CBCT cohort

    Subset of patients also assessed on CBCT.

    Diagnostic Test: Radiographic assessment (OPG / CBCT)

Interventions

  • Diagnostic testRadiographic assessment (OPG / CBCT)

    The radiographic assessment was performed on images that were already available. No additional exposure was required.

06

What researchers measure

Primary outcomes

  1. Primary

    Composite distal pathology of the mandibular second molar (distal caries, distal bone loss and/or external root resorption).

    Time frame: At the time of the radiographic examination (single cross-sectional assessment).

Secondary outcomes

  1. Secondary

    Agreement between OPG and CBCT measurements (ICC, weighted kappa, Bland-Altman).

    Time frame: At the time of the radiographic examination (single cross-sectional assessment).

07

Study locations

1 site
  • Clínica Universitaria UCAM Dental
    Murcia, Murcia 30008, Spain
08

References and documents

Individual participant data

Plan to share: No — Pseudonymised clinical images subject to GDPR; data available from the corresponding author upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2025 to primary completion in Jul 2026, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 13, 2026
StartActual
Oct 31, 2025
Primary completionActual
Jul 30, 2026
CompletionEst.
Dec 15, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07936253
Responsible party
Carlos Pérez-Albacete Martínez (Doctoral thesis supervisor, Universidad Católica San Antonio de Murcia) — Principal investigator
First posted
Nov 13, 2026
Start date
Oct 31, 2025
Primary completion
Jul 30, 2026
Completion
Dec 15, 2026 (estimated)
Last update
Nov 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion